Journals / Marmara Medical Journal / 1996 / Cilt: 9 - Sayı: 4

A successful multimodality treatment in a patient with resistant thrombotic thrombocytopenic purpura

Pages
188–191
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This observation led us to consider the importance of maintenance treatment in frequently relapsing TTP cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thrombotic thrombocytopenic purpura (TTP) is still a life threatening disease, despite vast developments in treatment modalities.
📊
Key Findings & Data:We report a case of severe TTP who did not respond to high dose intravenous steroids, plasmapheresis, defibrotide and splenectomy.
💡
Conclusion & Impact:This observation led us to consider the importance of maintenance treatment in frequently relapsing TTP cases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Thrombotic thrombocytopenic purpura (TTP) is still a life threatening disease, despite vast developments in treatment modalities. We report a case of severe TTP who did not respond to high dose intravenous steroids, plasmapheresis, defibrotide and splenectomy. However, after splenectomy with plasma replacement and intravenous immune globin infusion as a maintenance therapy, she improved and had durable complete remission. This observation led us to consider the importance of maintenance treatment in frequently relapsing TTP cases.

🔖

Cite This Article

ALPDOĞAN, Ö., BAYIK, M., AKOĞLU, T., ALPDOĞAN, T. B., DİRESKENELİ, H. (2022). A successful multimodality treatment in a patient with resistant thrombotic thrombocytopenic purpura. Marmara Medical Journal, Cilt: 9 - Sayı: 4, 188–191. https://ajindex.com/articles/578534

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...